Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents

QR Code

Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents

Renal impairment (RI) is known to be an independent risk factor for the progression of cardiovascular disease. Its impact, however, on the outcomes in patients undergoing percutaneous coronary intervention (PCI) especially in the era of drug-eluting stents (DES) is not well known. We analysed data f...

Full description

Bibliographic Details
Main Authors:	Shaw, J., Andrianopoulos, N., Duffy, S., Walton, A., Clark, D., Lew, R., Sebastian, M., New, G., Brennan, A., Reid, Christopher, Ajani, A.
Format:	Journal Article
Published:	2008
Online Access:	http://hdl.handle.net/20.500.11937/21663

Similar Items

Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry
by: Yan, B., et al.
Published: (2008)

Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents
by: Wilson, W., et al.
Published: (2011)

Rates of Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents (from a Large Australian Multicenter Registry)
by: Yan, B., et al.
Published: (2008)

The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents
by: Butler, M., et al.
Published: (2009)

Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents
by: Freeman, M., et al.
Published: (2009)

Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction
by: Gurvitch, R., et al.
Published: (2010)

Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)

A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era
by: Ariyaratne, T., et al.
Published: (2016)

Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary intervention
by: Wong, N., et al.
Published: (2022)

A PRACTICAL DEFINITION OF LATE STENT THROMBOSIS: INSIGHTS FROM THE MELBOURNE INTERVENTIONAL GROUP REGISTRY
by: Yan, B., et al.
Published: (2011)

IMPACT OF STENT DIAMETER ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH 2ND GENERATION DRUG ELUTING STENTS: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY
by: Plitt, A., et al.
Published: (2018)

Impact of renal function in patients with multi-vessel coronary disease on long-term mortality following coronary artery bypass grafting compared with percutaneous coronary intervention
by: Sugumar, H., et al.
Published: (2014)

Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Batchelor, R.J., et al.
Published: (2022)

PROLONGED EFFECTIVENESS OF CORONARY ARTERY BYPASS SURGERY VERSUS DRUG-ELUTING STENTS IN DIABETICS WITH MULTI-VESSEL DISEASE: AN UPDATED META-ANALYSIS
by: Ariyaratne, T., et al.
Published: (2012)

Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
by: Mohd Shah, Azarisman Shah, et al.
Published: (2011)

Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)

Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in Australia
by: Wlodarczyk, J., et al.
Published: (2015)

Recent trends in Australian percutaneous coronary intervention practice: Insights from the melbourne interventional group registry
by: Yan, B., et al.
Published: (2011)

Does the subtype of acute coronary syndrome treated by percutaneous coronary intervention predict long-term clinical outcomes?
by: Biswas, S., et al.
Published: (2018)

Heart Rate as a Predictor of Outcome Following Percutaneous Coronary Intervention
by: O'Brien, J., et al.
Published: (2018)

Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: An updated systematic review and meta-analysis
by: Ariyaratne, T., et al.
Published: (2014)

Incidence, Predictors and Clinical Outcomes of Stent Thrombosis Following Percutaneous Coronary Intervention in Contemporary Practice
by: Batchelor, R., et al.
Published: (2020)

Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
by: Al-Fiadh, A., et al.
Published: (2011)

Cardiovascular medication use following percutaneous coronary intervention: The Australian experience
by: Cole, J., et al.
Published: (2014)

Personalized 3D printed coronary models in coronary stenting
by: Sun, Zhonghua, et al.
Published: (2019)

Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromes
by: Yudi, M., et al.
Published: (2016)

Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.
by: Yudi, M., et al.
Published: (2016)

Stent Configurations And Its Effectiveness In Renal Artery Aneurysm
by: Bakar, Muhammad Haziq Abu
Published: (2019)

Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention
by: Ramzy, J., et al.
Published: (2019)

Pretreatment with Dual Antiplatelet Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention
by: Yudi, M., et al.
Published: (2015)

Role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI)
by: Freeman, M., et al.
Published: (2015)

TCT-250 Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry.
by: Papapostolou, S., et al.
Published: (2016)

Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)
by: Yeoh, J., et al.
Published: (2017)

Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): A multicentre Australian registry
by: Papapostolou, S., et al.
Published: (2018)

Effectiveness Of Variable Stent Designs For Treatment Of Renal Artery Aneurysm
by: Akashah, Akmal Rafiq
Published: (2018)

TemporalTrends of Heart Failure Patients Undergoing Percutaneous Coronary Intervention: Findings From Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2017)

Australian Trends in Procedural Characteristics and Outcomes in Patients Undergoing Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
by: Biswas, S., et al.
Published: (2017)

Coronary artery bypass grafting following stent restenosis
by: Sun, Zhonghua
Published: (2016)

Fenestrated stent graft repair of abdominal aortic aneurysm: Hemodynamic analysis of effect of fenestrated stents on renal arteries
by: Sun, Zhonghua, et al.
Published: (2010)

Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: Analysis of the Melbourne Interventional Group registry
by: Lu, K., et al.
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jhr6bpvv29t0uej2argifgsmnr